Trial Details
COMPLETEDBasic Information
| Clinical ID | c1862 |
|---|---|
| Identifier | NCT04318405 |
| Trial Title | Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Iron-Deficiency Anemia|Iron-Deficiency |
| Interventions | DRUG: Iron isomaltoside 1000 |
Participant Information
| Sponsor | Pierre Fabre Pharma AG |
|---|---|
| City | Basel |
| Country/Region | Switzerland |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2020-07-10 |
|---|---|
| Primary Completion Date | 2022-11-30 |
| Completion Date | 2022-11-30 |